[ Price : $8.95]
FDA grants Phanes Therapeutics a fast track designation for PT217 and its use in treating patients with extensive-stage small cell...[ Price : $8.95]
Harvard Medical School researchers say fewer than half of the cancer drugs given accelerated approval between 2013 and 2023 demons...[ Price : $8.95]
Federal Register notice: FDA makes available its annual compilation of update notices to the agencys Susceptibility Test Interpret...[ Price : $8.95]
FDA issues a written agreement with BrainStorm Cell Therapeutics under a Special Protocol Assessment on the design of the companys...[ Price : $8.95]
FDA warns Australias Antaria Pty. Ltd. about CGMP deviations in its production of active pharmaceutical ingredients.[ Price : $8.95]
A Congressional Research Service paper points to possible legislation Congress may want to consider to clarify how FDA is to use c...[ Price : $8.95]
A KFF Health News report carried online by NBC says 10 members of an FDA advisory committee evaluating an Abbott cardiac device ha...[ Price : $8.95]
CDER Office of Prescription Drug Promotion researchers say disclosing methodological rigor in communications to healthcare provide...